Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

In this 12-week, randomized, double-blind and double-dummy trial, intrajejunal infusion of levodopa-carbidopa gel decreased "off" time by almost 2 hours more than oral levodopa-carbidopa in individuals with Parkinson's disease suffering motor fluctuations.

Levodopa-Carbidopa Intraintestinal Infusion: Benefits in Advanced Parkinson's Disease